TIMP1 and prostate carcinoma: Consistently, WPE1-NB26-65, a malignant cell line derived from immortalized prostate epithelial cell line RWPE-1, expressed approximately 10 times more TIMP-1 than its parental cell line (Figure 1C-D), indicating that increased TIMP-1 expression is associated with prostate cancer progression.